Icon Bioscience, Inc. is developing a broad portfolio of proprietary, clinically superior pharmaceutical products based on Verisome® drug delivery technology and wide availability of generic drugs with established efficacy and safety profiles.  These products target several key ophthalmic indications, including but not limited to glaucoma, macular edema, inflammation/infection associated with cataract surgery and age-related macular degeneration (AMD).

Icon Bioscience, Inc., Pipeline includes products for drug dellivery on Verisome for cataract surgery, uveitis, glaucoma, dry AMD, retinoblastoma.

Icon Bioscience, Inc. | 1253 Reamwood Ave. | Sunnyvale, CA | 94089 | 650-369-4049
Copyright © 2014 Icon Bioscience, Inc. · Optimization by MME ·